Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia

[1] Canton R(2003)Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant J Antimicrobial Chemother 52 944-952

[2] Morosini M(2004): data from the global PROTEKT surveillance programme J Clin Microbiol 42 4980-4987

[3] Enright MC(2005)Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Antimicrob Agents Chemother 49 2903-2913

[4] Morrissey I(2003)collected during the 2000–2001 PROTEKT US Study Clin Infect Dis 37 1405-1433

[5] Brown SD(2004)Antimicrobial susceptibility of Antimicrob Agents Chemother 48 3491-3497

[6] Farrell DJ(2005)in eight European countries from 2001 to 2003 Lancet 365 579-587

[7] Morrissey I(2005)Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults Clin Infect Dis 41 560-564

[8] Reinert RR(2004)Levofloxacin-resistant invasive J Clin Microbiol 42 4686-4696

[9] Reinert S(1996)in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine Antimicrob Agents Chemother 40 2760-2764

[10] van der Linden M(1997)Outpatient antibiotic use in Europe and association with resistance: a cross-national database study Antimicrob Agents Chemother 41 1166-1167

[1] Canton R(2003)Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant J Antimicrobial Chemother 52 944-952

[2] Morosini M(2004): data from the global PROTEKT surveillance programme J Clin Microbiol 42 4980-4987

[3] Enright MC(2005)Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Antimicrob Agents Chemother 49 2903-2913

[4] Morrissey I(2003)collected during the 2000–2001 PROTEKT US Study Clin Infect Dis 37 1405-1433

[5] Brown SD(2004)Antimicrobial susceptibility of Antimicrob Agents Chemother 48 3491-3497

[6] Farrell DJ(2005)in eight European countries from 2001 to 2003 Lancet 365 579-587

[7] Morrissey I(2005)Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults Clin Infect Dis 41 560-564

[8] Reinert RR(2004)Levofloxacin-resistant invasive J Clin Microbiol 42 4686-4696

[9] Reinert S(1996)in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine Antimicrob Agents Chemother 40 2760-2764

[10] van der Linden M(1997)Outpatient antibiotic use in Europe and association with resistance: a cross-national database study Antimicrob Agents Chemother 41 1166-1167